General Notices

• Notice of Pre-Application Technical Assistance Webinar for RFA-AT-20-003, "Emotional Well-Being: High-Priority Research Networks (U24, Clinical Trial Optional)"
  (NOT-AT-20-008)
  National Center for Complementary and Integrative Health
  

• Notice of Pre-Application Technical Assistance NIH Videocast for RFA-AT-20-004, "HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)"
  (NOT-AT-20-009)
  National Center for Complementary and Integrative Health
  

• NIBIB Plans to Announce a Prize Competition: NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health
  (NOT-EB-20-001)
  National Institute of Biomedical Imaging and Bioengineering
  

• NIGMS Support for Biomedical Data Repositories and Biomedical Knowledgebases
  (NOT-GM-20-014)
  National Institute of General Medical Sciences
  

• Findings of Research Misconduct
  (NOT-OD-20-062)
  National Institutes of Health
  

• Notice of Pre-Application Webinar for RFA-RM-20-009, "MoTrPAC Phase 2 Animal Studies (U01 Clinical Trial Not Allowed)"
  (NOT-RM-20-007)
  Office of Strategic Coordination (Common Fund)
  

• Notice to Announce Request for Information to Assist in the Development of a New Strategic Plan for the National Institute on Deafness and Other Communication Disorders, for 2022-2026
  (NOT-DC-20-001)
  National Institute on Deafness and Other Communication Disorders
  

• Request for Information (RFI): Seeking Rapid Advancement of Research on Limb Regeneration
  (NOT-HD-20-004)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Request for Information (RFI): Inviting Comments and Suggestions for a Proposed Research Initiative to Decrease Maternal Mortality
  (NOT-OD-20-063)
  National Institutes of Health
  

Notice of Changes to Funding Opportunities

• Notice of NIAAA Participation in Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
  (NOT-AA-20-002)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of NIAAA Participation in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
  (NOT-AA-20-003)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Participation of the National Institute on Aging (NIA) in PAR-20-037 Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowe
  (NOT-AG-20-013)
  National Institute on Aging
  

• Notice of Participation of the National Institute on Aging (NIA) in PAR-20-038 Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
  (NOT-AG-20-014)
  National Institute on Aging
  

• Notice of Participation of the National Institute on Aging (NIA) in PA-18-870 BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)
  (NOT-AG-20-015)
  National Institute on Aging
  

• Notice of Participation of the National Institute on Aging (NIA) in PA-18-871 BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)
  (NOT-AG-20-016)
  National Institute on Aging
  

• Notice of Clarification of Eligibility for "Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp- Clinical Trial Not Allowed)"
  (NOT-AR-20-014)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Change to Due Dates and Application Types for NCCIH's PAR-18-662, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)"
  (NOT-AT-20-007)
  National Center for Complementary and Integrative Health
  

• Notice of National Cancer Institute (NCI) Participation in PAR-20-100 Genomic Community Resources (U24 Clinical Trial Not Allowed)
  (NOT-CA-20-027)
  National Cancer Institute
  

• Notice to Extend the Expiration Date of PAR-18-359: NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01-Clinical Trial Required)
  (NOT-DE-20-014)
  National Institute of Dental and Craniofacial Research
  

• Notice to Extend the Expiration Date of PAR-18-432: NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required)
  (NOT-DE-20-015)
  National Institute of Dental and Craniofacial Research
  

• Notice to Extend the Expiration Date of PAR-18-360: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22-Clinical Trial Required)
  (NOT-DE-20-016)
  National Institute of Dental and Craniofacial Research
  

• Notice of Change to PAR-19-330 "Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)"
  (NOT-HL-20-749)
  National Heart, Lung, and Blood Institute
  

• Notice of Correction of the Due Dates for Letters of Intent for RFA-MH-20-421, "NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth (K18 Clinical Trial Required)"
  (NOT-MH-20-032)
  National Institute of Mental Health
  

Funding Opportunities

• National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
  (PAR-20-077)
  National Cancer Institute
  Application Receipt Date(s): May 07, 2023
  
  

• IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
  (PAR-20-102)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 20, 2020; May 20, 2021; May 20, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
  (PAR-20-103)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 27, 2020; January 27, 2021; May 27, 2021; January 27, 2022; May 27, 2022; January 27, 2023
  
  

• Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)
  (RFA-AG-21-012)
  National Institute on Aging
  Application Receipt Date(s): June 17, 2020
  
  

• National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-AG-21-014)
  National Institute on Aging
  Application Receipt Date(s): June 17, 2020
  
  

• Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional)
  (RFA-AI-19-073)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 19, 2020
  
  

• Childhood Asthma in Urban Settings Clinical Research Network- Leadership Center (UM1 Clinical Trial Required)
  (RFA-AI-19-074)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 19, 2020
  
  

• Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)
  (RFA-ES-20-006)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): May 18, 2020, April 16, 2021, April 14, 2022. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats (UO1) Clinical Trials Not Allowed
  (RFA-FD-20-026)
  Food and Drug Administration
  Application Receipt Date(s): May 1, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.